News from the FDA/CDC

Children and COVID: Vaccination a harder sell in the summer


 

The COVID-19 vaccination effort in the youngest children has begun much more slowly than the most recent rollout for older children, according to the Centers for Disease Control and Prevention.

Almost 263,000 children under age 5 years were vaccinated in the first 2 weeks after final approval on June 18, compared with the over 3 million children aged 5-11 years who received their first dose during the 2 weeks after approval in early November of 2021, based on CDC data last updated on July 7.

Number of weekly COVID-19 cases reported in children, United States

That approval, of course, came between the Delta and Omicron surges, when awareness was higher. The low initial uptake among those under age 5, however, was not unexpected by the Biden administration. “That number in and of itself is very much in line with our expectation, and we’re eager to continue working closely with partners to build on this start,” a senior administration official told ABC News.

With approval of the vaccine occurring after the school year was over, parents’ thoughts have been focused more on vacations and less on vaccinations. “Even before these vaccines officially became available, this was going to be a different rollout; it was going to take more time,” the official explained.

Incidence measures continue on different paths

New COVID-19 cases dropped during the latest reporting week (July 1-7), returning to the downward trend that began in late May and then stopped for 1 week (June 24-30), when cases were up by 12.4%, according to the American Academy of Pediatrics and the Children’s Hospital Association.

First 2 weeks of COVID-19 vaccination in children after approval

Children also represent a smaller share of cases, probably because of underreporting. “There has been a notable decline in the portion of reported weekly COVID-19 cases that are children,” the two groups said in their weekly COVID report. Although “cases are likely increasingly underreported for all age groups, this decline indicates that children are disproportionately undercounted in reported COVID-19 cases.”

Other measures, however, have been rising slowly but steadily since the spring. New admissions of patients aged 0-17 years with confirmed COVID, which were down to 0.13 per 100,000 population in early April, had climbed to 0.39 per 100,000 by July 7, the CDC said on its COVID Data Tracker.

Emergency department visits continue to show the same upward trend, despite a small decline in early June. A COVID diagnosis was involved in just 0.5% of ED visits in children aged 0-11 years on March 26, but by July 6 the rate was 4.7%. Increases were not as high among older children: From 0.3% on March 26 to 2.5% on July 6 for those aged 12-15 and from 0.3% to 2.4% for 16- and 17-year-olds, according to the CDC.

Recommended Reading

Study confirms increased CVT with AstraZeneca COVID vaccine
MDedge Infectious Disease
What are the benefits of a fourth vaccination against COVID?
MDedge Infectious Disease
Skin reactions after COVID-19 vaccination have six patterns
MDedge Infectious Disease
Experimental cancer drug promising for hospitalized COVID patients
MDedge Infectious Disease
WHO tracking new Omicron subvariant in India
MDedge Infectious Disease
U.S. allows pharmacists to prescribe Paxlovid directly
MDedge Infectious Disease
‘Myriad’ dermatologic reactions after COVID-19 vaccination
MDedge Infectious Disease
Long COVID-19 in children and adolescents: What do we know?
MDedge Infectious Disease
Obesity links to faster fading of COVID vaccine protection
MDedge Infectious Disease
BA.4 and BA.5 subvariants are more evasive of antibodies, but not of cellular immunity
MDedge Infectious Disease